Table 2. Non-compliances identified in antiretroviral therapy after comparing to the Clinical Protocol and Therapy Guidelines.
| Description of non-compliance found | Regimens | Users treated with regimens not included in the PCDT |
|---|---|---|
| Monotherapy: treatment with only one drug | 7 (4.8) | 161 |
| Double therapy not allowed in the PCDT: treatment with only two drugs | 35 (23.8) | 207 |
| Low efficiency triple therapy | 17 (11.6) | 293 |
| Non association PI + ritonavir: mandatory association | 29 (19.7) | 340 |
| Double PI | 4 (2.7) | 4 |
| Triple NRTI | 26 (17.0) | 136 |
| Therapeutic duplicity | 4 (2.7) | 11 |
| Treatment regimens possibly guided by genotyping | 25 (17.0) | 50 |
Results expressed as (%) or n.
PCDT: Clinical Protocol and Therapy Guidelines; PI: protease inhibitor; NRTI: nucleoside analog reverse-transcriptase inhibitor.